PRESTIGE CONSUMER HEALTHCARE INC. (PBH) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $10.45M; Long-term Debt, Excluding Current MaturitiesUSD $2.01B; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD $410.45M.
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $0.00; Long-term Debt, Excluding Current MaturitiesUSD $993.95M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $993.95M; Long-Term Debt, Maturity, Year OneUSD $0.00.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $1.03B; Long-Term Debt, Maturity, Year OneUSD $0.00.
PRESTIGE CONSUMER HEALTHCARE INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.45M | $2.01B | (m) | $410.45M | $10.45M | $10.45M | $10.45M | (m) | (m) | $7.84M | $2.04B | $27.32M | (m) | (m) |
| 2026-03-31 | $0.00 | $993.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.00B | $6.05M | (m) | (m) |
| 2026-03-31 | (m) | (m) | $993.95M | $0.00 | $400.00M | $0.00 | $0.00 | $0.00 | $600.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | $1.03B | $0.00 | $400.00M | $40.00M | $0.00 | (m) | (m) | $0.00 | $1.04B | $6.45M | (m) | (m) |
| 2025-09-30 | (m) | (m) | $993.15M | $0.00 | $400.00M | $0.00 | $0.00 | (m) | (m) | $0.00 | $1.00B | $6.85M | (m) | (m) |
| 2025-06-30 | (m) | (m) | $992.75M | $0.00 | $400.00M | $0.00 | $0.00 | (m) | (m) | $0.00 | $1.00B | $7.25M | (m) | (m) |
| 2025-03-31 | (m) | (m) | $992.36M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.00B | $7.64M | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | $0.00 | $0.00 | $400.00M | $0.00 | $0.00 | $600.00M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $1.00B | $991.97M | $0.00 | $0.00 | $400.00M | $0.00 | (m) | (m) | $0.00 | $1.00B | $8.03M | (m) | (m) |
| 2024-09-30 | (m) | $1.06B | $1.05B | $0.00 | $0.00 | $400.00M | $60.00M | (m) | (m) | $0.00 | $1.06B | $8.41M | (m) | (m) |
| 2024-06-30 | (m) | $1.10B | $1.09B | $0.00 | $0.00 | $400.00M | $100.00M | (m) | (m) | $0.00 | $1.10B | $8.79M | (m) | (m) |
| 2024-03-31 | (m) | (m) | $1.13B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.14B | $9.20M | (m) | (m) |
| 2024-03-31 | (m) | $1.14B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | $0.00 | $0.00 | $0.00 | $400.00M | $135.00M | $600.00M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $1.21B | $1.20B | $0.00 | $0.00 | $0.00 | $400.00M | (m) | (m) | $0.00 | $1.21B | $10.66M | (m) | (m) |
| 2023-09-30 | (m) | $1.27B | $1.26B | $0.00 | $0.00 | $0.00 | $400.00M | (m) | (m) | $0.00 | $1.27B | $12.03M | (m) | (m) |
| 2023-06-30 | (m) | $1.33B | $1.32B | $0.00 | $0.00 | $0.00 | $400.00M | (m) | (m) | $0.00 | $1.33B | $13.29M | (m) | (m) |
| 2023-03-31 | (m) | $1.35B | $1.35B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.36B | $14.21M | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | $0.00 | $0.00 | $0.00 | $0.00 | $400.00M | $960.00M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $1.44B | $1.42B | $0.00 | $0.00 | $0.00 | $0.00 | (m) | (m) | $0.00 | $1.44B | $15.90M | (m) | (m) |
| 2022-09-30 | (m) | $1.46B | $1.44B | $0.00 | $0.00 | $0.00 | $0.00 | (m) | (m) | $0.00 | $1.46B | $16.66M | (m) | (m) |
| 2022-06-30 | (m) | $1.49B | $1.47B | $0.00 | $10.00M | $0.00 | $0.00 | (m) | (m) | $0.00 | $1.49B | $17.57M | (m) | (m) |
| 2022-03-31 | (m) | $1.48B | $1.48B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.50B | $18.34M | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.50B | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $1.55B | $1.53B | $0.00 | $0.00 | $0.00 | $0.00 | (m) | (m) | $0.00 | $1.55B | $19.70M | (m) | (m) |
| 2021-09-30 | $6.00M | $1.61B | $1.59B | $6.00M | $6.00M | $26.00M | $6.00M | (m) | (m) | $3.00M | $1.62B | $21.02M | (m) | (m) |
| 2021-06-30 | (m) | $1.55B | $1.55B | $0.00 | $475.00M | $85.00M | $0.00 | (m) | (m) | $0.00 | $1.56B | $14.65M | (m) | (m) |
| 2021-03-31 | (m) | $1.48B | $1.48B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.50B | $15.35M | (m) | (m) |
| 2021-03-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | $0.00 | $0.00 | $495.00M | $0.00 | $0.00 | $1.00B | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $1.55B | $1.55B | $0.00 | $0.00 | $1.16B | $0.00 | (m) | (m) | $0.00 | $1.56B | $11.31M | 5.38% | (m) |
| 2020-09-30 | (m) | $1.55B | $1.55B | $0.00 | $0.00 | $1.16B | $0.00 | (m) | (m) | $0.00 | $1.56B | $11.90M | (m) | (m) |
| 2020-06-30 | (m) | $1.62B | $1.62B | $0.00 | $0.00 | $1.23B | $0.00 | (m) | (m) | $0.00 | $1.63B | $13.36M | (m) | (m) |
| 2020-03-31 | (m) | $1.73B | $1.73B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.75B | $14.70M | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | $0.00 | $0.00 | $0.00 | $1.29B | $55.00M | $400.00M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 5.38% | (m) |
| 2019-12-31 | (m) | $1.70B | $1.70B | (m) | $0.00 | $0.00 | $0.00 | $1.32B | $400.00M | $0.00 | $1.72B | $15.69M | (m) | (m) |
| 2019-09-30 | (m) | $1.75B | $1.75B | (m) | $0.00 | $429.00M | $0.00 | $1.34B | $0.00 | $0.00 | $1.77B | $12.83M | (m) | (m) |
| 2019-06-30 | (m) | $1.78B | $1.78B | (m) | $0.00 | $455.00M | $0.00 | $1.34B | $0.00 | $0.00 | $1.79B | $13.62M | (m) | (m) |
| 2019-03-31 | (m) | $1.80B | $1.80B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.81B | $14.40M | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | $0.00 | $0.00 | $475.00M | $0.00 | $1.34B | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $1.84B | $1.84B | (m) | $0.00 | $0.00 | $475.00M | $0.00 | $1.38B | $0.00 | $1.86B | $15.71M | (m) | (m) |
| 2018-09-30 | (m) | $1.90B | $1.90B | (m) | $0.00 | $0.00 | $475.00M | $0.00 | $1.44B | $0.00 | $1.91B | $17.16M | (m) | (m) |
| 2018-06-30 | (m) | $1.99B | $1.99B | (m) | $0.00 | $0.00 | $475.00M | $437.00K | $1.54B | $0.00 | $2.01B | $19.20M | (m) | (m) |
| 2018-03-31 | (m) | $1.99B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $20.05M | (m) | (m) |
| 2018-03-31 | (m) | (m) | $1.99B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.01B | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | $0.00 | $0.00 | $0.00 | $477.00M | $9.75M | $1.53B | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $2.05B | (m) | (m) | $0.00 | $0.00 | $0.00 | $470.00M | $1.61B | $0.00 | $2.08B | $23.73M | (m) | (m) |
| 2017-09-30 | (m) | $2.09B | (m) | (m) | $0.00 | $0.00 | $0.00 | $490.00M | $1.63B | $0.00 | $2.12B | $24.91M | (m) | (m) |
| 2017-06-30 | (m) | $2.15B | (m) | (m) | $0.00 | $0.00 | $0.00 | $490.00M | $1.68B | $0.00 | $2.17B | $26.59M | (m) | (m) |
| 2017-03-31 | (m) | $2.19B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.22B | $28.27M | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | $0.00 | $0.00 | $0.00 | $12.08M | $504.27M | $1.71B | (m) | (m) | (m) | (m) | $28.27M |
| 2016-12-31 | (m) | $1.42B | (m) | (m) | $0.00 | $0.00 | $0.00 | $0.00 | $1.44B | $0.00 | $1.44B | $21.42M | (m) | $21.42M |
| 2016-09-30 | (m) | $1.48B | (m) | (m) | $0.00 | $0.00 | $0.00 | $65.00M | $1.44B | $0.00 | $1.50B | $22.30M | (m) | $22.34M |
| 2016-06-30 | (m) | $1.58B | (m) | (m) | $0.00 | $0.00 | $0.00 | $85.00M | $1.52B | $0.00 | $1.60B | $25.10M | (m) | $25.09M |
| 2016-03-31 | (m) | $1.63B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.65B | $27.19M | (m) | $27.19M |
| 2016-03-31 | (m) | (m) | (m) | $0.00 | $0.00 | $0.00 | $5.49M | $93.53M | $1.55B | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $1.45B | (m) | (m) | $0.00 | $0.00 | $6.97M | $258.52M | $1.21B | $0.00 | $1.48B | (m) | (m) | $30.47M |
| 2015-09-30 | (m) | $1.47B | (m) | (m) | $0.00 | $0.00 | $6.97M | $258.52M | $1.24B | $0.00 | $1.50B | (m) | (m) | $31.74M |
| 2015-06-30 | $8.53M | $1.51B | (m) | (m) | $8.53M | $8.53M | $8.53M | $258.52M | $1.26B | $6.39M | $1.55B | (m) | (m) | $33.53M |
| 2015-03-31 | (m) | $1.56B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.59B | $32.33M | (m) | $32.33M |
| 2015-03-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | $0.00 | $66.10M | $0.00 | $217.50M | $250.00M | $1.06B | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $1.64B | (m) | (m) | $0.00 | $66.10M | $0.00 | $247.50M | $1.33B | $0.00 | $1.64B | (m) | (m) | $5.64M |
| 2014-09-30 | $7.20M | $1.69B | (m) | (m) | $7.20M | $73.30M | $7.20M | $269.70M | $1.34B | $3.60M | $1.70B | (m) | (m) | $6.29M |
| 2014-06-30 | (m) | $969.56M | (m) | (m) | $0.00 | $35.00M | $0.00 | $287.50M | $650.00M | $0.00 | $972.50M | (m) | (m) | $2.94M |
| 2014-03-31 | (m) | $934.41M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $937.50M | (m) | (m) | $3.09M |
| 2014-03-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | $0.00 | $0.00 | $0.00 | $287.50M | $650.00M | $0.00 | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $981.51M | (m) | (m) | $0.00 | $0.00 | $37.50M | $0.00 | $947.50M | $48.29M | $1.03B | (m) | (m) | $3.49M |
| 2013-09-30 | (m) | $978.70M | (m) | (m) | $0.00 | $0.00 | $47.50M | $0.00 | $937.50M | $0.00 | $985.00M | (m) | (m) | $6.30M |
| 2013-06-30 | (m) | $953.25M | (m) | (m) | $0.00 | $0.00 | $15.00M | $0.00 | $945.00M | $0.00 | $960.00M | (m) | (m) | $6.75M |
| 2013-03-31 | (m) | $970.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $978.00M | (m) | (m) | $7.10M |
| 2013-03-31 | (m) | (m) | (m) | (m) | $0.00 | $0.00 | $33.00M | $0.00 | $945.00M | $0.00 | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $1.00B | (m) | (m) | $0.00 | $0.00 | $0.00 | $40.00M | $967.50M | $0.00 | $1.01B | (m) | (m) | $7.20M |
| 2012-09-30 | (m) | $1.08B | (m) | (m) | $0.00 | $0.00 | $0.00 | $25.00M | $1.06B | $0.00 | $1.09B | (m) | (m) | $10.28M |
| 2012-06-30 | (m) | $1.10B | (m) | (m) | $0.00 | $0.00 | $0.00 | $17.00M | $1.09B | $0.00 | $1.11B | (m) | (m) | $10.69M |
| 2012-03-31 | (m) | $1.12B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.14B | (m) | (m) | $11.09M |
| 2011-12-31 | (m) | $429.63M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.37M |
| 2011-09-30 | (m) | $447.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.60M |
| 2011-06-30 | (m) | $464.17M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $4.83M |
| 2011-03-31 | (m) | $486.94M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.05M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |